<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03997305</url>
  </required_header>
  <id_info>
    <org_study_id>1890</org_study_id>
    <nct_id>NCT03997305</nct_id>
  </id_info>
  <brief_title>AltaValve Early Feasibility Study Protocol</brief_title>
  <official_title>AltaValve Early Feasibility Study Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>4C Medical Technologies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>4C Medical Technologies, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, single-arm, multicenter study to evaluate the safety and performance of the&#xD;
      AltaValve for the treatment of moderate to severe or severe mitral valve regurgitation in&#xD;
      subjects who are considered high risk for mortality and morbidity from conventional&#xD;
      open-heart surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 4, 2019</start_date>
  <completion_date type="Anticipated">September 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major Adverse Cardiac Event</measure>
    <time_frame>30 days</time_frame>
    <description>Cardiac death, stroke, mitral valve related repeated intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>Index procedure completion (Day 0)</time_frame>
    <description>Technical Success per MVARC criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural success</measure>
    <time_frame>30 days</time_frame>
    <description>Device success and absence of major device or procedure related serious adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device success</measure>
    <time_frame>30 days</time_frame>
    <description>Device Success per MVARC criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in MR grade</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Mitral Regurgitation</condition>
  <condition>Mitral Insufficiency</condition>
  <condition>Mitral Valve Incompetence</condition>
  <condition>Mitral Valve Regurgitation</condition>
  <condition>Mitral Incompetence</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AltaValve</intervention_name>
    <description>Transcatheter Mitral Valve Replacement</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subjects ≥ 18 years of age.&#xD;
&#xD;
          2. Subjects symptomatic New York Heart Association (NYHA) II-IV.&#xD;
&#xD;
          3. Subjects with severe MR as documented by echo.&#xD;
&#xD;
          4. Subjects who are at high risk for open-heart surgery as documented by the health care&#xD;
             professional (e.g., Heart Team consisting of cardiac surgeon and interventional&#xD;
             cardiologist in United States).&#xD;
&#xD;
        Abbreviated Exclusion Criteria:&#xD;
&#xD;
          1. Inability to understand the study or a history of non-compliance with medical advice.&#xD;
&#xD;
          2. Unwilling or unable to sign the Informed Consent Form (ICF).&#xD;
&#xD;
          3. History of any cognitive or mental health status that would interfere with study&#xD;
             participation.&#xD;
&#xD;
          4. Currently enrolled in any other pre-approval investigational study (does not apply to&#xD;
             long-term post-market studies unless these studies might clinically interfere with the&#xD;
             current study endpoints (e.g., limit use of study-required medication, etc.)).&#xD;
&#xD;
          5. Female subjects who are pregnant or planning to become pregnant within the study&#xD;
             period.&#xD;
&#xD;
          6. Known hypersensitivity or contraindication to aspirin, heparin, or Warfarin without&#xD;
             adequate alternative medications.&#xD;
&#xD;
          7. Known hypersensitivity to nitinol (i.e., nickel allergy) that cannot be adequately&#xD;
             medicated.&#xD;
&#xD;
          8. Known hypersensitivity to contrast media that cannot be adequately medicated.&#xD;
&#xD;
          9. Evidence of current Left Ventricular Ejection Fraction (LVEF) ≤25% (where current is&#xD;
             defined as the latest LVEF measurement completed within 90 days prior to the index&#xD;
             procedure).&#xD;
&#xD;
         10. Concurrent medical condition with a life expectancy of less than 12 months.&#xD;
&#xD;
         11. Prior mitral valve repair/replacement (excluding prior surgical mitral valve repair,&#xD;
             annuloplasty, or MitraClip not interfering with AltaValve placement).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Genereux, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Morristown Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vinayak Bapat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Allina Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erika Youngstrom</last_name>
    <phone>+1-612-428-7130</phone>
    <email>altavalveEFS@4cmed.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>MedStar Washington Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin C Collins, MPH</last_name>
      <phone>202-877-6622</phone>
      <email>erin.c.collins@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Ron Waksman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Shultz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prairie Heart Institute</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62769</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Hudson</last_name>
      <phone>217-492-9100</phone>
      <phone_ext>29151</phone_ext>
      <email>shudson@prairieresearch.com</email>
    </contact>
    <contact_backup>
      <last_name>Melissa McHugh, MS</last_name>
      <phone>217-492-9100</phone>
      <phone_ext>29110</phone_ext>
      <email>MMchugh@prairieresearch.com</email>
    </contact_backup>
    <investigator>
      <last_name>Nilesh Goswami, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey Christy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Institute of the South</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Aucoin, LPN</last_name>
      <email>Jennifer.Aucoin@cardio.com</email>
    </contact>
    <investigator>
      <last_name>Peter Fail, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Donald Netherland, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham &amp; Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Downey, NP</last_name>
      <email>ldowney2@bwh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Tsuyoshi Kaneko, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pinak Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CentraCare Hearth and Vascular Center</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peggy Dahl, RN</last_name>
      <phone>320-251-2700</phone>
      <phone_ext>52187</phone_ext>
      <email>dahlp@centracare.com</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Humbert, BSN</last_name>
      <phone>320-251-2800</phone>
      <phone_ext>57560</phone_ext>
      <email>humbertj@centracare.com</email>
    </contact_backup>
    <investigator>
      <last_name>Thom Dahle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daren Danielson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine VanZile</last_name>
      <phone>201-787-2254</phone>
      <email>catherine.vanzile@atlantichealth.org</email>
    </contact>
    <investigator>
      <last_name>Philippe Genereux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Slater, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyn Santiago, RN</last_name>
      <email>lyn.santiago@chsli.org</email>
    </contact>
    <investigator>
      <last_name>George A Petrossian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Newell B Robinson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atrium Health</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bandaa Setliff, RN</last_name>
      <email>bandaa.setliff@atriumhealth.org</email>
    </contact>
    <investigator>
      <last_name>Michael Rinaldi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Skipper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NC Heart &amp; Vascular Research</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Lindner Research Center at The Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julianne O'Brien</last_name>
      <phone>513-585-1777</phone>
    </contact>
    <investigator>
      <last_name>Satya Shreenivas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>J Michael Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Green, RN, BSN</last_name>
      <phone>713-441-3629</phone>
      <email>lmgreen@houstonmethodist.org</email>
    </contact>
    <investigator>
      <last_name>Sachin Goel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Moritz Wyler von Ballmoos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Canada</country>
    <country>Japan</country>
  </removed_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 21, 2019</study_first_submitted>
  <study_first_submitted_qc>June 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2019</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mitral Regurgitation</keyword>
  <keyword>TMVR</keyword>
  <keyword>Functional Regurgitation</keyword>
  <keyword>Degenerative Regurgitation</keyword>
  <keyword>Transcathether Mitral Valve Replacement</keyword>
  <keyword>Primary Regurgitation</keyword>
  <keyword>Secondary Regurgitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

